Cargando…
(68)Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
PURPOSE: Clinically non-functioning pituitary macroadenomas (NFMA) have been reported to express somatostatin receptors (SSTR), but results are inconsistent across different studies. This may be related to limited sensitivity and specificity of techniques used to date, i.e. immunohistochemistry in s...
Autores principales: | Boertien, Tessel M., Booij, Jan, Majoie, Charles B. L. M., Drent, Madeleine L., Pereira, Alberto M., Biermasz, Nienke R., Simsek, Suat, Veldman, Ronald Groote, Stokkel, Marcel P. M., Bisschop, Peter H., Fliers, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218160/ https://www.ncbi.nlm.nih.gov/pubmed/34191241 http://dx.doi.org/10.1186/s41824-020-0073-3 |
Ejemplares similares
-
The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a (68)Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size
por: Boertien, Tessel M, et al.
Publicado: (2020) -
Chiasmal herniation following treatment of pituitary macroadenoma
por: Tabak, Marjolein, et al.
Publicado: (2020) -
Twins in spirit - episode I: comparative preclinical evaluation of [(68)Ga]DOTATATE and [(68)Ga]HA-DOTATATE
por: Schottelius, Margret, et al.
Publicado: (2015) -
High Prevalence of Metabolic Syndrome Features in Patients Previously Treated for Nonfunctioning Pituitary Macroadenoma
por: Joustra, Sjoerd D., et al.
Publicado: (2014) -
Predicting [(177)Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [(68)Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling
por: Siebinga, Hinke, et al.
Publicado: (2023)